Division of Neurosurgery, Arkansas Children's Hospital, Little Rock, Arkansas, USA,
Division of Neurosurgery, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Pediatr Neurosurg. 2022;57(3):175-183. doi: 10.1159/000523779. Epub 2022 Feb 24.
The literature indicates that decompression of Chiari I malformations (CM-1) may resolve symptoms of sleep apnea. This study aims to identify the incidence of obstructive sleep apnea (OSA), central sleep apnea (CSA), and mixed sleep apnea in a cohort of pediatric CM-1 patients treated at our institution. We also assessed apnea-hypopnea index and symptomatology before and after surgery to investigate if Chiari decompression is a viable treatment for sleep apnea in CM-1 patients. Improvement relative to ENT surgical intervention was also considered.
We identified 75 patients who underwent polysomnography (PSG) from our database of 465 CM-1 patients. Sleep apnea diagnosis was based on the sleep physician's overall interpretation of the PSG. Symptomatology pre- and post-surgery was analyzed.
Of the 75 CM-1 patients that underwent PSG, 23 were diagnosed with sleep apnea. Sixteen had OSA, 6 had CSA, and 1 had mixed apnea. Twelve OSA patients received ENT intervention. Eight improved and 2 further improved after Chiari decompression. Of the 4 patients that did not improve, one of those later improved following Chiari decompression. Of the 6 CSA patients, 2 underwent Chiari decompression, but only one improved. The mixed apnea patient underwent several ENT interventions that did not relieve symptoms but improved following Chiari decompression.
DISCUSSION/CONCLUSIONS: Based on our results, sleep apnea in CM-1 patients may be obstructive, central, or mixed and is likely multifactorial. A multidisciplinary approach to the management of these patients is important, including neurosurgery, otolaryngology, and sleep medicine. Future prospective studies will lend further insight into this condition and its management.
文献表明 Chiari I 畸形(CM-1)减压可能会缓解睡眠呼吸暂停症状。本研究旨在确定我院治疗的小儿 CM-1 患者队列中阻塞性睡眠呼吸暂停(OSA)、中枢性睡眠呼吸暂停(CSA)和混合性睡眠呼吸暂停的发生率。我们还评估了手术前后的呼吸暂停低通气指数和症状,以研究 Chiari 减压是否是 CM-1 患者睡眠呼吸暂停的可行治疗方法。还考虑了与耳鼻喉科手术干预的相对改善。
我们从 465 例 CM-1 患者的数据库中确定了 75 例接受多导睡眠图(PSG)的患者。睡眠呼吸暂停的诊断基于睡眠医师对 PSG 的整体解读。分析了手术前后的症状。
在接受 PSG 的 75 例 CM-1 患者中,23 例被诊断为睡眠呼吸暂停。16 例为 OSA,6 例为 CSA,1 例为混合性呼吸暂停。12 例 OSA 患者接受了耳鼻喉科干预。8 例在 Chiari 减压后改善,2 例进一步改善。在未改善的 4 例患者中,其中 1 例在 Chiari 减压后改善。6 例 CSA 患者中,2 例接受 Chiari 减压,但只有 1 例改善。混合性呼吸暂停患者接受了多次耳鼻喉科干预,但未缓解症状,随后 Chiari 减压后症状改善。
讨论/结论:根据我们的结果,CM-1 患者的睡眠呼吸暂停可能是阻塞性、中枢性或混合性的,可能是多因素的。对这些患者进行多学科管理非常重要,包括神经外科、耳鼻喉科和睡眠医学。未来的前瞻性研究将进一步深入了解这种情况及其管理。